51 related articles for article (PubMed ID: 11500516)
1. Multiple ErbB-2/Neu Phosphorylation Sites Mediate Transformation through Distinct Effector Proteins.
Dankort D; Jeyabalan N; Jones N; Dumont DJ; Muller WJ
J Biol Chem; 2001 Oct; 276(42):38921-8. PubMed ID: 11500516
[TBL] [Abstract][Full Text] [Related]
2. Expanding the Disorder-Function Paradigm in the C-Terminal Tails of Erbbs.
Pinet L; Assrir N; van Heijenoort C
Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827688
[TBL] [Abstract][Full Text] [Related]
3. Structural and dynamic characterization of the C-terminal tail of ErbB2: Disordered but not random.
Pinet L; Wang YH; Deville C; Lescop E; Guerlesquin F; Badache A; Bontems F; Morellet N; Durand D; Assrir N; van Heijenoort C
Biophys J; 2021 May; 120(10):1869-1882. PubMed ID: 33741354
[TBL] [Abstract][Full Text] [Related]
4. SH3BGRL confers innate drug resistance in breast cancer by stabilizing HER2 activation on cell membrane.
Li H; Zhang M; Wei Y; Haider F; Lin Y; Guan W; Liu Y; Zhang S; Yuan R; Yang X; Yang S; Wang H
J Exp Clin Cancer Res; 2020 May; 39(1):81. PubMed ID: 32381043
[TBL] [Abstract][Full Text] [Related]
5. Combined targeting of Raf and Mek synergistically inhibits tumorigenesis in triple negative breast cancer model systems.
Nagaria TS; Shi C; Leduc C; Hoskin V; Sikdar S; Sangrar W; Greer PA
Oncotarget; 2017 Oct; 8(46):80804-80819. PubMed ID: 29113345
[TBL] [Abstract][Full Text] [Related]
6. Emerging roles for LPP in metastatic cancer progression.
Ngan E; Kiepas A; Brown CM; Siegel PM
J Cell Commun Signal; 2018 Mar; 12(1):143-156. PubMed ID: 29027626
[TBL] [Abstract][Full Text] [Related]
7. Aberrant Signaling through the HER2-ERK1/2 Pathway is Predictive of Reduced Disease-Free and Overall Survival in Early Stage Non-Small Cell Lung Cancer (NSCLC) Patients.
Scrima M; Zito Marino F; Oliveira DM; Marinaro C; La Mantia E; Rocco G; De Marco C; Malanga D; De Rosa N; Rizzuto A; Botti G; Franco R; Zoppoli P; Viglietto G
J Cancer; 2017; 8(2):227-239. PubMed ID: 28243327
[No Abstract] [Full Text] [Related]
8. PTPRO represses ERBB2-driven breast oncogenesis by dephosphorylation and endosomal internalization of ERBB2.
Dong H; Ma L; Gan J; Lin W; Chen C; Yao Z; Du L; Zheng L; Ke C; Huang X; Song H; Kumar R; Yeung SC; Zhang H
Oncogene; 2017 Jan; 36(3):410-422. PubMed ID: 27345410
[TBL] [Abstract][Full Text] [Related]
9. Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression.
Boulay PL; Mitchell L; Turpin J; Huot-Marchand JÉ; Lavoie C; Sanguin-Gendreau V; Jones L; Mitra S; Livingstone JM; Campbell S; Hallett M; Mills GB; Park M; Chodosh L; Strathdee D; Norman JC; Muller WJ
Cancer Res; 2016 May; 76(9):2662-74. PubMed ID: 26933086
[TBL] [Abstract][Full Text] [Related]
10. Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.
Hu X; Fan Q; Hou H; Yan R
J Neurochem; 2016 Jan; 136(2):234-49. PubMed ID: 26465092
[TBL] [Abstract][Full Text] [Related]
11. "PEST control": regulation of molecular barcodes by tyrosine phosphatases.
Doody KM; Bottini N
Cell Res; 2014 Sep; 24(9):1027-8. PubMed ID: 25081059
[TBL] [Abstract][Full Text] [Related]
12. The catalytic region and PEST domain of PTPN18 distinctly regulate the HER2 phosphorylation and ubiquitination barcodes.
Wang HM; Xu YF; Ning SL; Yang DX; Li Y; Du YJ; Yang F; Zhang Y; Liang N; Yao W; Zhang LL; Gu LC; Gao CJ; Pang Q; Chen YX; Xiao KH; Ma R; Yu X; Sun JP
Cell Res; 2014 Sep; 24(9):1067-90. PubMed ID: 25081058
[TBL] [Abstract][Full Text] [Related]
13. The ShcA adaptor activates AKT signaling to potentiate breast tumor angiogenesis by stimulating VEGF mRNA translation in a 4E-BP-dependent manner.
Im YK; La Selva R; Gandin V; Ha JR; Sabourin V; Sonenberg N; Pawson T; Topisirovic I; Ursini-Siegel J
Oncogene; 2015 Mar; 34(13):1729-35. PubMed ID: 24837366
[TBL] [Abstract][Full Text] [Related]
14. Trastuzumab-induced recruitment of Csk-homologous kinase (CHK) to ErbB2 receptor is associated with ErbB2-Y1248 phosphorylation and ErbB2 degradation to mediate cell growth inhibition.
Dokmanovic M; Wu Y; Shen Y; Chen J; Hirsch DS; Wu WJ
Cancer Biol Ther; 2014 Aug; 15(8):1029-41. PubMed ID: 24835103
[TBL] [Abstract][Full Text] [Related]
15. When Good Turns Bad: Regulation of Invasion and Metastasis by ErbB2 Receptor Tyrosine Kinase.
Brix DM; Clemmensen KK; Kallunki T
Cells; 2014 Jan; 3(1):53-78. PubMed ID: 24709902
[TBL] [Abstract][Full Text] [Related]
16. Coarse-grained molecular simulation of epidermal growth factor receptor protein tyrosine kinase multi-site self-phosphorylation.
Koland JG
PLoS Comput Biol; 2014 Jan; 10(1):e1003435. PubMed ID: 24453959
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer.
Allen-Petersen BL; Carter CJ; Ohm AM; Reyland ME
Oncogene; 2014 Mar; 33(10):1306-15. PubMed ID: 23474764
[TBL] [Abstract][Full Text] [Related]
18. Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor β (TGFβ)-induced breast cancer cell migration, invasion, and metastasis.
Northey JJ; Dong Z; Ngan E; Kaplan A; Hardy WR; Pawson T; Siegel PM
J Biol Chem; 2013 Feb; 288(7):5210-22. PubMed ID: 23277357
[TBL] [Abstract][Full Text] [Related]
19. Ste20-like kinase SLK, at the crossroads: a matter of life and death.
Al-Zahrani KN; Baron KD; Sabourin LA
Cell Adh Migr; 2013; 7(1):1-10. PubMed ID: 23154402
[TBL] [Abstract][Full Text] [Related]
20. Trastuzumab and lapatinib modulation of HER2 tyrosine/threonine phosphorylation and cell signaling.
Kostyal D; Welt RS; Danko J; Shay T; Lanning C; Horton K; Welt S
Med Oncol; 2012 Sep; 29(3):1486-94. PubMed ID: 21769502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
